Complete Vaccine Index
All 266 vaccines, antitoxins, and biological preparations — alphabetical listing
This index lists all 266 vaccine products cataloged on VaccinationFacts.com in alphabetical order. Each entry links to its disease category page for full regulatory details, manufacturer information, and historical context. The index includes currently licensed products, discontinued vaccines, historical milestones, and pre-1940 commercial bacterins.
Last updated: April 2026.
| Trade Name | Generic Designation | Manufacturer | Category | Status |
|---|---|---|---|---|
| Abrysvo | RSV vaccine (bivalent, prefusion F) | Pfizer | RSV | FDA Licensed, 2023 |
| ACAM2000 | Smallpox and mpox (vaccinia) vaccine, live | Emergent BioSolutions | Mpox/Smallpox | FDA Licensed, 2007 |
| ACEL-IMUNE | DTaP | Wyeth-Lederle | Combination | FDA Licensed; Discontinued |
| Acne Bacterin | Bacterin — Acne vulgaris | H.K. Mulford Co. | Pre-1940 Bacterin | 1900s-1930s |
| ActHIB | Hib conjugate vaccine (tetanus toxoid conjugate) | Sanofi Pasteur | Hib | FDA Licensed, 1993 |
| Adacel | Tdap (tetanus, diphtheria, acellular pertussis) | Sanofi Pasteur | Combination | FDA Licensed, 2005 |
| Adenovirus Type 4 and 7 Vaccine | Adenovirus Type 4 and Type 7 vaccine, live oral | Teva (Barr) | Adenovirus | FDA Licensed, 2011 |
| Adjupanrix | H1N1 pandemic influenza vaccine | GSK | Influenza | EMA Authorized, 2009 |
| Afluria Quadrivalent | Influenza vaccine | Seqirus (CSL) | Influenza | FDA Licensed |
| Agriflu | Influenza virus vaccine | Seqirus | Influenza | FDA Licensed |
| AIDSVAX | HIV gp120 subunit vaccine | VaxGen | HIV (failed) | Phase III failed, 2003 |
| Almevax | Rubella vaccine (RA 27/3) | Wellcome | Rubella | Licensed (UK); Discontinued |
| Anti-Plague Serum | Antiserum — Plague | Various (Haffkine Institute) | Pre-1940 Bacterin | 1897-1930s |
| Apexxnar | PCV20 (international name) | Pfizer | Pneumococcal | EMA Authorized |
| AREPANRIX | H5N1 monovalent vaccine, adjuvanted | GSK | Influenza | FDA Licensed, 2024 |
| Arexvy | RSV vaccine (adjuvanted) | GSK | RSV | FDA Licensed, 2023 |
| Attenuvax | Measles virus vaccine, live-attenuated | Merck | Measles | FDA Licensed, 1963; Discontinued |
| AUDENZ | H5N1 monovalent vaccine, adjuvanted | Seqirus | Influenza | FDA Licensed, 2020 |
| Avaxim | Hepatitis A vaccine, inactivated | Sanofi Pasteur | Hepatitis A | Licensed (non-US) |
| b-CAPSA-1 | Hib polysaccharide vaccine | Praxis Biologics | Hib | FDA Licensed; Discontinued |
| BCG (generic) | Bacillus Calmette-Guérin live-attenuated M. bovis | Various (Merck, Sanofi, others) | BCG/Tuberculosis | FDA Licensed (Merck TICE strain) |
| Bexsero | MenB-4C vaccine | GSK (Novartis legacy) | Meningococcal | FDA Licensed, 2015 |
| Biavax | Rubella-Mumps vaccine | Merck | Combination | FDA Licensed; Discontinued |
| Bio-Hep-B | Hepatitis B vaccine (recombinant) | Various | Hepatitis B | Licensed (various) |
| Biopolio | Bivalent oral poliovirus vaccine (bOPV) | Bharat Biotech | Polio | WHO Prequalified |
| BioThrax | Anthrax vaccine adsorbed (AVA) | Emergent BioSolutions | Anthrax | FDA Licensed, 1970 |
| Boostrix | Tdap | GSK | Combination | FDA Licensed, 2005 |
| Calmette-Guérin BCG | Bacillus Calmette-Guérin | Albert Calmette / Camille Guérin | Historical | 1921 |
| CAPVAXIVE | Pneumococcal 21-valent conjugate vaccine (PCV21) | Merck | Pneumococcal | FDA Licensed, 2024 |
| Cendevax | Rubella vaccine (Cendehill strain) | SKF/GSK | Rubella | Licensed (UK); Discontinued |
| Certiva | DTaP | North American Vaccine | Combination | FDA Licensed; Discontinued |
| Cervarix | HPV bivalent (16,18) vaccine | GSK | HPV | FDA Licensed, 2009 |
| Cervavac | HPV quadrivalent vaccine | Serum Institute of India | HPV | Licensed in India, 2022 |
| Coley's Toxins | Bacterial toxin — Cancer (therapeutic) | William Coley / Parke-Davis | Pre-1940 Bacterin | 1891-1960s |
| Comirnaty | BNT162b2 mRNA COVID-19 vaccine | Pfizer-BioNTech | COVID-19 | FDA Licensed, 2021 |
| Comvax | Hib-HepB combination | Merck | Hepatitis B | FDA Licensed, 1996; Discontinued |
| Comvax | Hib-HepB combination | Merck | Hib | FDA Licensed, 1996; Discontinued |
| Corbevax | COVID-19 RBD protein subunit vaccine | Biological E | COVID-19 | India EUA, 2021 |
| CoronaVac | Inactivated whole-virus COVID-19 vaccine | Sinovac | COVID-19 | WHO EUL, 2021 |
| COVAXIN | BBV152 whole-virion inactivated COVID-19 vaccine | Bharat Biotech | COVID-19 | WHO EUL, 2021 (suspended 2022) |
| COVIFENZ | CoVLP plant-derived VLP vaccine | Medicago | COVID-19 | Health Canada, 2022; Withdrawn |
| Covishield | ChAdOx1-S COVID-19 vaccine (SII) | Serum Institute of India | COVID-19 | WHO EUL, 2021 |
| Cyfendus | Anthrax vaccine adsorbed, adjuvanted (AV7909) | Emergent BioSolutions | Anthrax | FDA Licensed, 2023 |
| Daptacel | DTaP (diphtheria, tetanus, acellular pertussis) | Sanofi Pasteur | Combination | FDA Licensed, 2002 |
| Decavac | Td (tetanus + diphtheria adult) | Sanofi Pasteur | Diphtheria | FDA Licensed |
| Dengvaxia | CYD-TDV live-attenuated tetravalent dengue | Sanofi Pasteur | Dengue | FDA Licensed, 2019 |
| Dick Toxin-Antitoxin | Toxin-antitoxin — Scarlet fever (active immunization) | Various | Pre-1940 Bacterin | 1920s |
| Diphtheria antitoxin (equine) | Horse-derived anti-diphtheria serum | Historical | Diphtheria | Historical (1890s) |
| Diphtheria Toxin-Antitoxin (TAT) | Toxin-antitoxin — Diphtheria (active immunization) | Multiple | Pre-1940 Bacterin | 1913-1940s |
| Diphtheria toxoid | Formaldehyde-inactivated diphtheria toxin | Various | Diphtheria | Licensed (in combinations) |
| DPT (whole-cell) | Diphtheria-pertussis-tetanus (whole-cell) | Various | Historical | 1948 |
| Dryvax | Smallpox vaccine (dried calf lymph) | Wyeth | Mpox/Smallpox | FDA Licensed; Discontinued |
| Dukoral | Oral killed whole-cell + recombinant B-subunit (WC-rBS) | Valneva | Cholera | WHO Prequalified |
| Encepur | TBE vaccine | GSK (Novartis legacy) | Tick-Borne Encephalitis | EMA Authorized |
| Enders Measles Vaccine | Edmonston B measles vaccine | John Enders | Historical | 1963 |
| Engerix-B | Hepatitis B vaccine (recombinant) | GSK | Hepatitis B | FDA Licensed, 1989 |
| Epaxal | Hepatitis A vaccine, virosomal | Crucell/Janssen | Hepatitis A | Licensed (non-US); Discontinued |
| ERVEBO | Ebola Zaire vaccine, live (rVSV-ZEBOV) | Merck | Ebola | FDA Licensed, 2019 |
| Ervevax | Rubella vaccine (RA 27/3) | SKB/GSK | Rubella | Licensed (EU); Discontinued |
| Euvax B | Hepatitis B vaccine (recombinant) | LG Chem | Hepatitis B | WHO Prequalified |
| Fendrix | Hepatitis B vaccine, adjuvanted (AS04) | GSK | Hepatitis B | EMA Authorized |
| Fluad / Fluad Quadrivalent | Influenza vaccine, adjuvanted | Seqirus (CSL) | Influenza | FDA Licensed, 2015 |
| Fluarix Quadrivalent | Influenza virus vaccine | GSK | Influenza | FDA Licensed |
| Flublok / Flublok Quadrivalent | Influenza vaccine (recombinant) | Sanofi Pasteur | Influenza | FDA Licensed, 2013 |
| Flucelvax Quadrivalent | Influenza vaccine (cell culture) | Seqirus (CSL) | Influenza | FDA Licensed, 2012 |
| Fluenz Tetra | Influenza vaccine, live intranasal | AstraZeneca | Influenza | EMA Authorized |
| FluLaval Quadrivalent | Influenza virus vaccine | GSK (ID Biomedical) | Influenza | FDA Licensed |
| FluMist | Influenza vaccine, live intranasal | MedImmune/AstraZeneca | Influenza | FDA Licensed, 2003 |
| Fluogen | Influenza virus vaccine | Parke-Davis | Influenza | Discontinued |
| Flushield | Influenza virus vaccine | Wyeth | Influenza | Discontinued |
| Fluvirin | Influenza virus vaccine | Seqirus | Influenza | FDA Licensed; Discontinued |
| Fluzone / Fluzone HD | Influenza virus vaccine (inactivated) | Sanofi Pasteur | Influenza | FDA Licensed |
| Focetria | H1N1 pandemic influenza vaccine | Novartis (now Seqirus) | Influenza | EMA Authorized, 2009 |
| FSME-Immun | TBE vaccine | Pfizer (Baxter legacy) | Tick-Borne Encephalitis | EMA Authorized |
| Gardasil | HPV quadrivalent (6,11,16,18) vaccine | Merck | HPV | FDA Licensed, 2006 |
| Gardasil 9 | HPV 9-valent vaccine | Merck | HPV | FDA Licensed, 2014 |
| Gene Vac-B | Hepatitis B vaccine (recombinant) | Serum Institute of India | Hepatitis B | Licensed in India |
| GenH-B-Vax | Hepatitis B vaccine (plasma-derived) | Pasteur Mérieux | Hepatitis B | Licensed (France); Discontinued |
| GenHevac-B | Hepatitis B vaccine (CHO cell recombinant) | Pasteur Mérieux | Hepatitis B | Licensed (France); Discontinued |
| Gonococcal Bacterin | Bacterin — Gonorrhea | H.K. Mulford Co. | Pre-1940 Bacterin | 1900s-1930s |
| H-B-Vax | Hepatitis B vaccine (plasma-derived) | Merck | Hepatitis B | Discontinued |
| H1N1 2009 Monovalent | Influenza A (H1N1) 2009 vaccine | Multiple (Sanofi, CSL, MedImmune, Novartis, ID Bio) | Influenza | FDA Licensed, 2009 |
| H5N1 Stockpile Vaccine | Influenza virus vaccine H5N1 | Sanofi Pasteur | Influenza | FDA Licensed, 2007 |
| Haffkine Cholera Vaccine | Killed whole-cell cholera vaccine | Waldemar Haffkine | Historical | 1893 |
| Haffkine Plague Vaccine | Killed whole-cell plague vaccine | Waldemar Haffkine | Historical | 1897 |
| Hantavax | Inactivated hantavirus vaccine | Korea Green Cross | Hantavirus | Licensed in South Korea |
| Havrix | Hepatitis A vaccine, inactivated | GSK | Hepatitis A | FDA Licensed, 1995 |
| HBVaxPro | Hepatitis B vaccine (recombinant) | Merck (MSD) | Hepatitis B | EMA Authorized |
| Heberbiovac HB | Hepatitis B vaccine (recombinant) | Heber Biotec (Cuba) | Hepatitis B | WHO Prequalified |
| Hecolin | Hepatitis E vaccine (recombinant) | Xiamen Innovax | Hepatitis E | Licensed in China, 2011 |
| Hepacare | Hepatitis B vaccine (3-antigen) | Medeva/Acambis | Hepatitis B | Licensed (UK); Discontinued |
| Hepavax-Gene | Hepatitis B vaccine (recombinant) | Janssen (Korea) | Hepatitis B | Licensed in Asia |
| Heplisav-B | Hepatitis B vaccine (recombinant), adjuvanted | Dynavax | Hepatitis B | FDA Licensed, 2017 |
| Heprecomb | Hepatitis B vaccine (recombinant) | Berna/Crucell | Hepatitis B | Licensed (non-US); Discontinued |
| Heptavax-B | Plasma-derived hepatitis B vaccine | Merck | Hepatitis B | FDA Licensed, 1981; Discontinued |
| Hevac-B | Hepatitis B vaccine (plasma-derived) | Pasteur Vaccins | Hepatitis B | Licensed (France); Discontinued |
| Hexaxim / Hexyon | DTaP-IPV-Hib-HepB | Sanofi Pasteur | Combination | EMA Authorized |
| HIB-IMUNE | Hib conjugate vaccine (PRP-D) | Lederle | Hib | FDA Licensed; Discontinued |
| HIB-Vax | Hib polysaccharide vaccine | Connaught | Hib | FDA Licensed, 1985; Discontinued |
| Hiberix | Hib conjugate vaccine (tetanus toxoid conjugate) | GSK | Hib | FDA Licensed, 2009 |
| HibTITER | Hib conjugate vaccine (CRM197 conjugate) | Wyeth-Lederle | Hib | FDA Licensed, 1988; Discontinued |
| Hilleman Mumps Vaccine | Jeryl Lynn strain mumps vaccine | Maurice Hilleman | Historical | 1967 |
| HINVAC | H1N1 influenza vaccine | Various (India) | Influenza | Licensed in India |
| Imojev | JE vaccine, live-attenuated chimeric | Sanofi Pasteur | Japanese Encephalitis | Licensed in Australia/Asia |
| Imovax Rabies | Rabies vaccine (human diploid cell) | Sanofi Pasteur | Rabies | FDA Licensed, 1980 |
| INCOVACC | BBV154 intranasal COVID-19 vaccine | Bharat Biotech | COVID-19 | India EUA, 2022 |
| Indirab | Rabies vaccine (Vero cell) | Bharat Biotech | Rabies | Licensed in India |
| Infanrix | DTaP | GSK | Combination | FDA Licensed, 1997 |
| Infanrix Hexa | DTaP-IPV-Hib-HepB hexavalent | GSK | Hepatitis B | EMA Authorized |
| Infanrix Hexa | DTaP-IPV-Hib-HepB | GSK | Combination | EMA Authorized |
| Influvac | Influenza vaccine (surface antigen) | Abbott/Mylan | Influenza | Licensed (non-US) |
| IPOL | Poliovirus vaccine inactivated (Vero cell) | Sanofi Pasteur | Polio | FDA Licensed, 1987 |
| IXCHIQ | Chikungunya vaccine, live-attenuated (VLA1553) | Valneva | Chikungunya | FDA Licensed, 2023 |
| Ixiaro | JE vaccine, inactivated (Vero cell) | Valneva | Japanese Encephalitis | FDA Licensed, 2009 |
| JE-Vax | JE vaccine (mouse brain-derived) | BIKEN/Sanofi | Japanese Encephalitis | FDA Licensed; Discontinued 2005 |
| Jennerian Smallpox Vaccine | Cowpox-derived inoculation | Edward Jenner | Historical | 1796 |
| JENVAC | JE vaccine, inactivated (Vero cell) | Bharat Biotech | Japanese Encephalitis | Licensed in India |
| JYNNEOS / Imvamune | Smallpox and monkeypox vaccine, live non-replicating | Bavarian Nordic | Mpox/Smallpox | FDA Licensed, 2019 |
| Kinrix | DTaP-IPV | GSK | Combination | FDA Licensed, 2008 |
| Koch Tuberculin | Tuberculin extract | Robert Koch | Historical | 1890 |
| Koprowski OPV (experimental) | Oral poliovirus vaccine (experimental) | Hilary Koprowski | Historical | 1950 |
| Lancy-Vaxina | Calf lymph smallpox vaccine | Swiss Serum Institute | Mpox/Smallpox | Historical; Discontinued |
| Lirugen / Mevilin-L | Measles vaccine formulations | Various (historical) | Measles | Historical / Discontinued |
| LYMErix | Lyme disease vaccine (OspA) | GSK (SmithKline Beecham) | Lyme Disease | FDA Licensed, 1998; Withdrawn 2002 |
| M-M-R II | Measles, mumps, rubella vaccine | Merck | Measles | FDA Licensed, 1978 |
| M-M-R II | Measles, mumps, rubella | Merck | Combination | FDA Licensed, 1978 |
| M-Vac | Measles vaccine | Various (historical) | Measles | Historical; Discontinued |
| Maupas/Blumberg Hepatitis B Vaccine | Plasma-derived hepatitis B vaccine | Philippe Maupas / Baruch Blumberg | Historical | 1976 |
| MCV4 (generic) | Various quadrivalent meningococcal | Various | Meningococcal | Various |
| Measles-K / M-Vac | Various measles vaccine formulations | Various (historical) | Measles | Historical |
| Menactra | MenACWY-DT conjugate vaccine | Sanofi Pasteur | Meningococcal | FDA Licensed, 2005 |
| MenAfriVac | MenA conjugate vaccine | Serum Institute of India | Meningococcal | WHO Prequalified |
| Mencevax | MenACWY polysaccharide vaccine | GSK | Meningococcal | Licensed (non-US); Discontinued |
| Menhibrix | MenCY-Hib conjugate vaccine | GSK | Meningococcal | FDA Licensed, 2012; Discontinued |
| Meningitec | MenC conjugate vaccine | Pfizer (Wyeth) | Meningococcal | Licensed (non-US) |
| Meningococcal Antiserum | Antiserum — Meningococcal meningitis | Various | Pre-1940 Bacterin | 1906-1940s |
| Menjugate | MenC conjugate vaccine | GSK (Novartis) | Meningococcal | Licensed (non-US) |
| Menomune | MenACWY polysaccharide vaccine | Sanofi Pasteur | Meningococcal | FDA Licensed; Discontinued |
| MenQuadfi | MenACWY-TT conjugate vaccine | Sanofi Pasteur | Meningococcal | FDA Licensed, 2020 |
| Menveo | MenACWY-CRM conjugate vaccine | GSK (Novartis legacy) | Meningococcal | FDA Licensed, 2010 |
| Meruvax II | Rubella virus vaccine, live (RA 27/3) | Merck | Rubella | FDA Licensed, 1967; Discontinued |
| Mevilin-L | Measles vaccine | Various (historical) | Measles | Historical; Discontinued |
| Mixed Bacterin (stock) | Polyvalent bacterin — Multiple infections | H.K. Mulford / Parke-Davis | Pre-1940 Bacterin | 1900s-1930s |
| MNEXSPIKE | COVID-19 vaccine, mRNA | Manufacturer TBD | COVID-19 | FDA Licensed, 2025 |
| Moniarix | Pneumococcal conjugate vaccine | GSK | Pneumococcal | Licensed (non-US); Discontinued |
| Mosquirix (RTS,S/AS01) | Malaria vaccine | GSK | Malaria | WHO Recommended, 2021 |
| mRESVIA | RSV vaccine (mRNA) | Moderna | RSV | FDA Licensed, 2024 |
| Mumpsvax | Mumps virus vaccine, live (Jeryl Lynn) | Merck | Mumps | FDA Licensed, 1967; Discontinued |
| Mycobax | BCG vaccine | Sanofi Pasteur | BCG/Tuberculosis | Licensed (non-US) |
| NeisVac-C | MenC conjugate vaccine | Pfizer | Meningococcal | Licensed (non-US) |
| Nimenrix | MenACWY-TT conjugate vaccine | Pfizer (GSK legacy) | Meningococcal | EMA Authorized |
| Nuvaxovid | NVX-CoV2373 protein subunit COVID-19 vaccine | Novavax | COVID-19 | FDA Licensed, 2023 |
| OmniHIB | Hib conjugate vaccine (PRP-T) | SmithKline Beecham | Hib | FDA Licensed; Discontinued |
| Orimune | Oral poliovirus vaccine (OPV, Sabin) | Wyeth-Lederle | Polio | FDA Licensed; Discontinued in US 2000 |
| Pandemrix | H1N1 pandemic influenza vaccine | GSK | Influenza | EMA Authorized, 2009 |
| Pasteur Cholera Vaccine | Attenuated cholera cultures | Louis Pasteur / Jaime Ferrán | Historical | 1885 |
| Pasteur Rabies Vaccine | Nerve tissue rabies vaccine | Louis Pasteur | Historical | 1885 |
| Pediacel | DTaP-IPV-Hib | Sanofi Pasteur | Combination | Licensed (non-US) |
| Pediarix | DTaP-HepB-IPV combination | GSK | Hepatitis B | FDA Licensed, 2002 |
| Pediarix | DTaP-HepB-IPV | GSK | Combination | FDA Licensed, 2002 |
| PedvaxHIB | Hib conjugate vaccine (meningococcal protein conjugate) | Merck | Hib | FDA Licensed, 1989 |
| Penbraya | MenABCWY vaccine | Pfizer | Meningococcal | FDA Licensed, 2023 |
| Penbraya | MenABCWY | Pfizer | Combination | FDA Licensed, 2023 |
| Penmenvy | MenABCWY vaccine | Sanofi | Meningococcal | FDA Licensed, 2025 |
| Penmenvy | MenABCWY | Sanofi | Combination | FDA Licensed, 2025 |
| Pentacel | DTaP-IPV/Hib combination | Sanofi Pasteur | Hib | FDA Licensed, 2008 |
| Pentacel | DTaP-IPV/Hib | Sanofi Pasteur | Combination | FDA Licensed, 2008 |
| Pertussis Bacterin | Bacterin — Whooping cough | Multiple | Pre-1940 Bacterin | 1914-1940s |
| Plague Vaccine | Plague vaccine | Greer Labs | Plague | FDA Licensed; Discontinued |
| Plotkin Rubella Vaccine (RA 27/3) | Human diploid cell rubella vaccine | Stanley Plotkin | Historical | 1969 |
| Pluserix | MMR vaccine | SKB/GSK | Combination | Licensed (non-US); Withdrawn |
| Pneumococcal Antiserum (type-specific) | Antiserum — Pneumococcal pneumonia | Swiss Serum Institute / others | Pre-1940 Bacterin | 1910s-1940s |
| Pneumococcal Bacterin | Bacterin — Pneumococcal infections | H.K. Mulford Co. | Pre-1940 Bacterin | 1900s-1930s |
| Pneumovax 23 | Pneumococcal polysaccharide vaccine (PPSV23) | Merck | Pneumococcal | FDA Licensed, 1983 |
| Pnu-Imune | Pneumococcal polysaccharide (PPSV) | Wyeth-Lederle | Pneumococcal | Discontinued |
| Pnu-Imune 23 | Pneumococcal polysaccharide vaccine (PPSV23) | Wyeth-Lederle | Pneumococcal | FDA Licensed; Discontinued |
| Polimylex | Inactivated poliovirus vaccine | Sanofi Pasteur | Polio | Licensed (non-US) |
| Poliovax | Poliovirus vaccine inactivated (human diploid) | Sanofi Pasteur | Polio | FDA Licensed |
| PreHevbrio | Hepatitis B vaccine (recombinant) | VBI Vaccines | Hepatitis B | FDA Licensed, 2021 |
| Prevenar 13 | PCV13 (international name) | Pfizer | Pneumococcal | EMA Authorized |
| Prevnar (PCV7) | Pneumococcal 7-valent conjugate vaccine | Pfizer (Wyeth) | Pneumococcal | FDA Licensed, 2000; Discontinued |
| Prevnar 13 | Pneumococcal 13-valent conjugate vaccine (PCV13) | Pfizer | Pneumococcal | FDA Licensed, 2010 |
| Prevnar 20 | Pneumococcal 20-valent conjugate vaccine (PCV20) | Pfizer | Pneumococcal | FDA Licensed, 2021 |
| Priorix | Measles, mumps, rubella vaccine | GSK | Measles | FDA Licensed, 2022 |
| Priorix | Measles, mumps, rubella | GSK | Combination | FDA Licensed, 2022 |
| ProHIBIT | Hib polysaccharide-diphtheria toxoid conjugate | Connaught/Pasteur Mérieux | Hib | FDA Licensed, 1987; Discontinued |
| ProQuad | MMRV (measles, mumps, rubella, varicella) | Merck | Combination | FDA Licensed, 2005 |
| Provenge | Sipuleucel-T (autologous cellular immunotherapy) | Dendreon | Cancer (therapeutic) | FDA Licensed, 2010 |
| Pumarix | H5N1 pandemic influenza vaccine | GSK | Influenza | EMA Authorized |
| Qdenga | TAK-003 live-attenuated tetravalent dengue | Takeda | Dengue | EMA Authorized, 2022 |
| Quadracel | DTaP-IPV | Sanofi Pasteur | Combination | FDA Licensed, 2015 |
| Quimi-Hib | Hib synthetic conjugate vaccine | Finlay Institute (Cuba) | Hib | Licensed in Cuba |
| Quinvaxem | DTP-HepB-Hib pentavalent | Novartis/Biological E | Combination | WHO Prequalified; Discontinued |
| RabAvert | Rabies vaccine (purified chick embryo cell) | GSK (Bavarian Nordic) | Rabies | FDA Licensed, 1997 |
| Rabipur | Rabies vaccine (purified chick embryo cell) | GSK/Bavarian Nordic | Rabies | EMA Authorized |
| Recombivax HB | Hepatitis B vaccine (recombinant) | Merck | Hepatitis B | FDA Licensed, 1986 |
| Refortrix | Tdap | GSK | Combination | Licensed (non-US) |
| Repevax | Tdap-IPV | Sanofi Pasteur | Combination | Licensed (EU) |
| Revac-B | Hepatitis B vaccine (recombinant) | Bharat Biotech | Hepatitis B | Licensed in India |
| Revaxis | Td-IPV (tetanus-diphtheria-polio) | Sanofi Pasteur | Combination | Licensed (EU) |
| Rotarix | Rotavirus vaccine, live oral (monovalent) | GSK | Rotavirus | FDA Licensed, 2008 |
| RotaShield | Rotavirus vaccine, live oral (rhesus-based) | Wyeth-Lederle | Rotavirus | FDA Licensed, 1998; Withdrawn 1999 |
| RotaTeq | Rotavirus vaccine, live oral (pentavalent) | Merck | Rotavirus | FDA Licensed, 2006 |
| Rotavac | Rotavirus vaccine (116E strain) | Bharat Biotech | Rotavirus | WHO Prequalified, 2018 |
| Rubeovax | Rubella vaccine | Various | Rubella | Discontinued |
| Rucelvax | Rubella vaccine | Various | Rubella | Discontinued |
| Rutter/Valenzuela Recombinant HBV | Recombinant hepatitis B vaccine | William Rutter / Pablo Valenzuela | Historical | 1986 |
| Sabin OPV | Oral poliovirus vaccine (live-attenuated) | Albert Sabin | Historical | 1961 |
| Sabin-Feldman Toxoplasma Research | Toxoplasma research | Albert Sabin / H.A. Feldman | Historical | 1948 |
| Salk IPV | Inactivated poliovirus vaccine | Jonas Salk | Historical | 1955 |
| Scarlet Fever Streptococcus Antitoxin | Antitoxin — Scarlet fever | Burroughs Wellcome | Pre-1940 Bacterin | 1900s-1920s |
| Sci-B-Vac | Hepatitis B vaccine (recombinant, 3-antigen) | VBI Vaccines | Hepatitis B | Licensed in Israel/EU |
| Shanchol | Oral killed whole-cell bivalent cholera vaccine | Sanofi (Shantha) | Cholera | WHO Prequalified |
| Shanvac-B | Hepatitis B vaccine (recombinant) | Shantha Biotechnics | Hepatitis B | WHO Prequalified |
| Shingrix | Zoster vaccine recombinant, adjuvanted | GSK | Shingles | FDA Licensed, 2017 |
| Smorodintsev Live Influenza Vaccine | Live-attenuated influenza vaccine | Anatoli Smorodintsev | Historical | 1936 |
| Spikevax | mRNA-1273 COVID-19 vaccine | Moderna | COVID-19 | FDA Licensed, 2022 |
| Sputnik V | Gam-COVID-Vac adenovirus vector | Gamaleya (Russia) | COVID-19 | Not WHO prequalified |
| Stamaril | Yellow fever vaccine (17D-204) | Sanofi Pasteur | Yellow Fever | Licensed (non-US) |
| Staphylococcal Bacterin | Bacterin — Staphylococcal infections | Parke-Davis & Co. | Pre-1940 Bacterin | 1900s-1930s |
| Streptococcal Bacterin | Bacterin — Streptococcal infections | Parke-Davis & Co. | Pre-1940 Bacterin | 1900s-1930s |
| Supemtek | Influenza vaccine (recombinant) | Sanofi Pasteur | Influenza | EMA Authorized |
| Synflorix | Pneumococcal 10-valent conjugate vaccine (PCV10) | GSK | Pneumococcal | WHO Prequalified |
| TAB Vaccine | Typhoid-paratyphoid A & B vaccine | Military programs | Historical | 1896 |
| Takahashi Varicella Vaccine (Oka) | Oka strain varicella vaccine | Michiaki Takahashi | Historical | 1974 |
| TDVAX | Td (tetanus + diphtheria adult) | MassBiologics | Combination | FDA Licensed |
| Tenivac | Td (tetanus + diphtheria adult) | Sanofi Pasteur | Combination | FDA Licensed |
| Tetanus antitoxin (equine) | Horse-derived anti-tetanus serum | Various | Tetanus | Historical (1890s) |
| Tetanus Antitoxin (equine) | Antitoxin — Tetanus | Burroughs Wellcome / others | Pre-1940 Bacterin | 1890s-present |
| Tetanus toxoid | Formaldehyde-inactivated tetanus toxin | Various | Tetanus | FDA Licensed, 1938 |
| Theiler Yellow Fever 17D | Yellow fever vaccine strain 17D | Max Theiler | Historical | 1937 |
| TICE-BCG | BCG vaccine (Tice strain) | Merck | BCG/Tuberculosis | FDA Licensed |
| Ticovac | Tick-borne encephalitis vaccine | Pfizer | Tick-Borne Encephalitis | FDA Licensed, 2021 |
| Tri-Immunol | DTP (whole-cell pertussis) | Wyeth-Lederle | Combination | FDA Licensed; Discontinued |
| Tri-Immunol (alt) | DTP (whole-cell) | Lederle | Combination | Discontinued |
| Tri-Solgen | DTP (whole-cell) | Wyeth | Combination | Discontinued |
| TriHIBit | DTaP/Hib combination | Sanofi Pasteur | Hib | FDA Licensed; Discontinued |
| Trihibit | DTaP/Hib | Sanofi Pasteur | Combination | FDA Licensed; Discontinued |
| Tripedia | DTaP | Sanofi Pasteur (Aventis) | Combination | FDA Licensed, 1992; Discontinued |
| Trivax | DTP (whole-cell) | Wellcome | Combination | Discontinued |
| Trumenba | MenB-FHbp vaccine | Pfizer | Meningococcal | FDA Licensed, 2014 |
| Twinrix | Hepatitis A + Hepatitis B vaccine | GSK | Hepatitis B | FDA Licensed, 2001 |
| Twinrix | Hepatitis A + Hepatitis B | GSK | Combination | FDA Licensed, 2001 |
| Typbar-TCV | Typhoid conjugate vaccine (Vi-TT) | Bharat Biotech | Typhoid | WHO Prequalified, 2017 |
| Typherix | Typhoid Vi polysaccharide vaccine | GSK | Typhoid | Licensed (non-US) |
| Typhim Vi | Typhoid Vi polysaccharide vaccine | Sanofi Pasteur | Typhoid | FDA Licensed, 1994 |
| Typhoid Bacterin (TAB) | Bacterin — Typhoid fever | Multiple (Mulford, Parke-Davis, military) | Pre-1940 Bacterin | 1896-1940s |
| Vaqta | Hepatitis A vaccine, inactivated | Merck | Hepatitis A | FDA Licensed, 1996 |
| Varilrix | Varicella virus vaccine, live | GSK | Varicella | Licensed (non-US) |
| Varivax | Varicella virus vaccine, live | Merck | Varicella | FDA Licensed, 1995 |
| Vaxchora | Oral cholera vaccine, live-attenuated CVD 103-HgR | Emergent BioSolutions (PaxVax) | Cholera | FDA Licensed, 2016 |
| Vaxelis | DTaP-IPV-Hib-HepB hexavalent | MSP Vaccine Co (Merck/Sanofi) | Hepatitis B | FDA Licensed, 2018 |
| Vaxelis | DTaP-IPV-Hib-HepB hexavalent | MSP Vaccine Co | Hib | FDA Licensed, 2018 |
| Vaxelis | DTaP-IPV-Hib-HepB | MSP Vaccine Co (Merck/Sanofi) | Combination | FDA Licensed, 2018 |
| Vaxigrip | Influenza vaccine (split virion) | Sanofi Pasteur | Influenza | Licensed (non-US) |
| Vaxneuvance | Pneumococcal 15-valent conjugate vaccine (PCV15) | Merck | Pneumococcal | FDA Licensed, 2022 |
| Vaxzevria | ChAdOx1-S COVID-19 vaccine | AstraZeneca | COVID-19 | EMA Authorized, 2021; Withdrawn 2024 |
| Verorab | Rabies vaccine (Vero cell) | Sanofi Pasteur | Rabies | WHO Prequalified |
| VIMKUNYA | Chikungunya vaccine, recombinant | Bavarian Nordic | Chikungunya | FDA Licensed, 2025 |
| Vivotif | Typhoid vaccine live oral Ty21a | Emergent BioSolutions (PaxVax) | Typhoid | FDA Licensed, 1989 |
| Von Behring Diphtheria Antitoxin | Horse-derived diphtheria serum | Emil von Behring | Historical | 1891 |
| Von Behring Tetanus Antitoxin | Horse-derived tetanus serum | Emil von Behring / Kitasato | Historical | 1890 |
| Weigl Typhus Vaccine | Louse-gut typhus vaccine | Rudolf Weigl | Historical | 1930 |
| YF-Vax | Yellow fever vaccine (17D-204) | Sanofi Pasteur | Yellow Fever | FDA Licensed |
| Zabdeno + Mvabea | Ad26.ZEBOV + MVA-BN-Filo (2-dose regimen) | Janssen/Bavarian Nordic | Ebola | EMA Authorized, 2020 |
| Zostavax | Zoster vaccine, live (Oka/Merck) | Merck | Shingles | FDA Licensed, 2006; Discontinued 2020 |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026), EMA Medicines database, and WHO Prequalified Vaccines list. Catalog scope and historical context informed by Khan, Shaz, The Ultimate Vaccine Timeline.